Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
First Year
100%
Multi-institutional Study
100%
Pediatric Heart Transplant
100%
Donor-specific Antibodies
100%
Positive Crossmatch
100%
Transplantation
50%
Incidence Rate
50%
CDC Crossmatch
50%
High Risk
25%
Immunosuppression
25%
North America
25%
Pretransplant
25%
Between-group
25%
Corticosteroids
25%
Retransplantation
25%
Hemodynamic Compromise
25%
Positive Groups
25%
Cellular Rejection
25%
Heart Transplant Recipients
25%
Antibody-mediated Rejection
25%
Waitlist Mortality
25%
Waiting Time
25%
Antibody Status
25%
Intravenous Immunoglobulin (IVIg)
25%
HLA Antibodies
25%
Transplant Waiting List
25%
Single Antigen Bead
25%
Antibody Removal
25%
Complement-dependent Cytotoxicity Crossmatch
25%
Immunology and Microbiology
Immunosuppression
100%
Intravenous Immunoglobulin
100%
Hemodynamic
100%
Heart Transplantation
100%
Sensitization
100%
HLA Antibody
100%
Complement Dependent Cytotoxicity
100%
Medicine and Dentistry
Pediatrics
100%
Heart Transplantation
100%
Immunosuppressive Treatment
50%
Immunoglobulin
50%
Hemodynamic
50%
Heart Graft
50%
Retransplantation
50%
Cellular Rejection
50%
Sensitization
50%
HLA Antibody
50%
Complement Dependent Cytotoxicity
50%